NEW YORK, May 6 American OrientalBioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceuticalcompany dedicated to improving health through the development, manufacture andcommercialization of a broad range of prescription and over the counter ("OTC")products, today announced that it plans to release first quarter 2010financial results on Monday, May 10, 2010, before the market opens.
The Company will hold a conference call at 8:00 am ET on Monday, May 10,to discuss its results. Listeners may access the call by dialing1-866-804-6927 or 1-857-350-1673 for international callers, access code:92995812. A webcast will also be available through AOB's website athttp://www.bioaobo.com .
A replay of the call will be available through May 17, 2010. Listenersmay access the replay by dialing 1-888-286-8010 or 1-617-801-6888 forinternational callers, access code: 50942560.
About American Oriental Bioengineering, Inc.
American Oriental Bioengineering, Inc. is a pharmaceutical companydedicated to improving health through the development, manufacture andcommercialization of a broad range of prescription and over the counterproducts.
Statements made in this press release are forward-looking and are madepursuant to the safe harbor provisions of the Securities Litigation Reform Actof 1995. Such statements involve risks and uncertainties that may causeactual results to differ materially from those set forth in these statements.The economic, competitive, governmental, technological and other factorsidentified in the Company's filings with the Securities and ExchangeCommission, including the Form 10-K for the year ended December 31, 2008, maycause actual results or events to differ materially from those described inthe forward looking statements in this press release. The Company undertakesno obligation to publicly update or revise any forward-looking statements,whether because of new information, future events, or otherwise.
Integrated Corporate Relations, Inc.
Ashley M. Ammon
SOURCE American Oriental Bioengineering, Inc.